Patent ID: 9393314
Filing Date: 2016-07-19
CPC Classification: A61K,A61P

Claim Text:
1. A meloxicam eyedrop, characterized in that, the meloxicam eyedrop comprises active ingredient meloxicam or a pharmaceutically acceptable salt thereof, a solubilizer, a stabilizer, a pH regulator, an osmotic pressure regulator and optionally a bacteriostatic agent, wherein the solubilizer is selected from the group consisting of hydroxypropyl-β-cyclodextrin, sulfobutylether-β-cyclodextrin, and β-cyclodextrin or a mixture thereof; wherein the stabilizer is selected from the group consisting of sodium hyaluronate, and hydroxypropyl methyl cellulose or a mixture thereof; wherein the pH regulator is selected from the group consisting of hydrochloric acid, boric acid, borax, sodium dihydrogen phosphate, disodium hydrogen phosphate, potassium dihydrogen phosphate, citric acid, and sodium citrate or a mixture thereof; wherein the osmotic pressure regulator is selected from the group consisting of sodium chloride, potassium chloride, boric acid, borax, sodium sulfate, potassium sulfate, sodium nitrate, potassium nitrate, sodium acetate, mannitol, glycerol, propylene glycol, and glucose or a mixture thereof; and wherein the bacteriostatic agent is selected from the group consisting of methyl paraben, ethyl paraben, propyl paraben, butyl paraben, benzalkonium chloride, benzalkonium bromide, chlorhexidine acetate, phenylmercuric nitrate, and thimerosal or a mixture thereof.